Blood sample collection for telomere biomarker analysis
Diagnostic TestPeripheral blood samples will be collected to measure telomere-related biomarkers that will be used for the development of a predictive algorithm.
Other names: Blood sample
NCT Number: NCT07465848
This research is a clinical performance study of in vitro diagnostic device (IVD), a prospective, multicentre, open-label, case-control clinical investigation aimed at constructing a predictive model that allows results to be classified as positive or negative in relation to the probability of having lung cancer.
Interested in participating?
Request Info45 year and older
All sexes
Interventional
Not applicable
Hospital General Universitario de Elche, Elche, Alicante, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Case Group:
Control Group:
Cohort A (High risk controls):
Cohort B (Low-risk controls):
Exclusion criteria
Peripheral blood samples will be collected to measure telomere-related biomarkers that will be used for the development of a predictive algorithm.
Other names: Blood sample
Laboratory analysis of telomere-associated biomarkers in blood samples to generate data for the development of a predictive clinical algorithm.
Other names: Blood sample
Time frame: At study enrollment
Time frame: At study enrollment
To determine the algorithm's ability to detect lung cancer by analysing its sensitivity, specificity, positive and negative predictive values, and overall accuracy.
Interested in participating?
Request InfoGrupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Other
Acronym: PneumoTAV001
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07761351
Disease, Lung Cancer (Diagnosis)
Basel, Canton of Basel-City, Switzerland
View Trial DetailsNCT07827183
Disease, Lung Cancer (Diagnosis)
Siping, Jilin, China
View Trial DetailsNCT07824583
Abdominal Cancer, Adenocarcinoma
St Louis, Missouri, United States
View Trial DetailsNCT07806682
Disease, Lung Cancer (Diagnosis)
Taipei, Taiwan
View Trial Details